Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome

Author： Ozmen V.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.68, Iss.2, 2001-07, pp. : 147-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer

By              

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 331-335

Spandidos Publications

Access to resources Recommend Favorite

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

By Fernández-Sánchez Mónica   Gamboa-Dominguez Armando   Uribe Norma   García-Ulloa Ana   Flores-Estrada Diana   Candelaria Myrna   Arrieta Oscar  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 171-183

Humana Press, Inc

Access to resources Recommend Favorite

Treatment Response to Preoperative Anthracycline-Based Chemotherapy in Locally Advanced Breast Cancer: The Relevance of Proliferation and Apoptosis Rates

By Kanjer Ksenija  

Pathology & Oncology Research, Vol. 19, Iss. 3, 2013-07 ,pp. : 577-588

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/neu expression as a predictive factor for response to anthracycline-based chemotherapy in a Mexican Population of locally advanced breast cancer patients

By Muñoz-Gonzalez David   Zeichner-Gancz Isabel   Candelaria Myrna   Ramirez-Ugalde Maria   Perez-Sanchez Manuel   Cervantes-Vazquez Guadalupe   Cantu-de Leon David   Mora-Tizcareño Arcelia   Leonor-Ortíz Julio  

Medical Oncology, Vol. 22, Iss. 1, 2005-03 ,pp. : 23-28

Humana Press, Inc

Access to resources Recommend Favorite

Clinical significance of Smac and survivin expression in breast cancer patients treated with anthracyclinebased neoadjuvant chemotherapy

By              

Molecular Medicine Reports, Vol. 9, Iss. 2, 2014-01 ,pp. : 614-620

Spandidos Publications

Access to resources Recommend Favorite